Victory Capital Management
CRBU icon

Victory Capital Management’s Caribou Biosciences CRBU Stock Holding History

Victory Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,143
Closed -$19.9K – 2485
2024
Q3 		$19.9K Sell
10,143
-173
-2% -$354 ﹤0.01% 2444
2024
Q2 		$16.9K Buy
10,316
+85
+0.8% +$272 ﹤0.01% 2439
2024
Q1 		$52.6K Buy
+10,231
New +$63.1K ﹤0.01% 2373
2022
Q1 		– Sell
-81,160
Closed -$1.23M – 2740
2021
Q4 		$1.23M Sell
81,160
-3,770
-4% -$73.3K ﹤0.01% 1746
2021
Q3 		$2.03M Buy
+84,930
New +$2.08M ﹤0.01% 1599

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's CRBU Position: Q4 2024 in Review

Victory Capital Management sold out of Caribou Biosciences (CRBU) in Q4 2024, closing a stake of 10,143 shares — an estimated $19.9K sold.

Victory Capital Management first reported a position in CRBU in Q3 2021 and held it in 5 quarters. The position peaked at $2.03M in Q3 2021. 133 funds tracked by Wall St. Rank hold CRBU as of Q4 2024.

  • Victory Capital Management reported no remaining Caribou Biosciences position as of Q4 2024 after selling out during the quarter.
  • Victory Capital Management sold 10,143 Caribou Biosciences shares in Q4 2024, an estimated $19.9K.
  • Victory Capital Management first reported a position in Caribou Biosciences in Q3 2021 and held it in 5 quarters.
  • Victory Capital Management's Caribou Biosciences position peaked at $2.03M in Q3 2021.
  • 133 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2024.

Based on Victory Capital Management's 13F filing for Q4 2024, filed 6 Feb 2025.